No Data
Hengsheng Pharmaceutical-B (02137) granted a total of 14.66 million share purchase rights and 1.555 million restricted share units.
Tencent Bo Medicine - B (02137) announced that the content involves (i) the initial public offering share incentive plan and initial...
Express News | National Medical Products Administration: Deploys pilot work on segmented production reform of biological products.
Sudden Movement Spotlight | Biomedical Class B shares rose in the afternoon, LKYG-B up 30%, institutions bullish on sector further recovery space
Biomedical Class B shares rose in the afternoon, as of the time of publication, Lai Kai Medicine-B rose by 27.88%, to 7.89 Hong Kong dollars; YimingAngke-B rose by 17.91%, to 5.86 Hong Kong dollars; Yasheng Medicine-B rose by 5.74%, to 46.95 Hong Kong dollars.
Who's buying? The A-share market is closed, but the Hong Kong stock market is still going strong! There's a big shift in foreign capital underway.
According to the latest report published by Goldman Sachs, after the People's Bank of China announced easing measures and the September Political Bureau meeting, mainland consumer stocks rebounded strongly by an average of about 32% in the past week.
Express News | Hong Kong stock CRO concept stocks soared at the close, what happened?
BRII-B: 2024 Interim Report
No Data
No Data